| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
|
Schöffski, P.
|
|
|
21 |
10 |
p. 1990-1998
|
article
|
| 2 |
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
|
El-Rayes, B.F.
|
|
|
21 |
10 |
p. 1999-2004
|
article
|
| 3 |
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)
|
Jatoi, A.
|
|
|
21 |
10 |
p. 2040-2044
|
article
|
| 4 |
Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?
|
Terschüren, C.
|
|
|
21 |
10 |
p. 2045-2051
|
article
|
| 5 |
Assessing oncologic benefit in clinical trials of immunotherapy agents
|
Hales, R.K.
|
|
|
21 |
10 |
p. 1944-1951
|
article
|
| 6 |
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study
|
Price, T.J.
|
|
|
21 |
10 |
p. 2121
|
article
|
| 7 |
Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer
|
Shimura, T.
|
|
|
21 |
10 |
p. 2005-2010
|
article
|
| 8 |
Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma
|
Niitsu, N.
|
|
|
21 |
10 |
p. 2069-2074
|
article
|
| 9 |
Corrections to “Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
|
|
|
|
21 |
10 |
p. 2127
|
article
|
| 10 |
Editorial Board
|
|
|
|
21 |
10 |
p. ii-iii
|
article
|
| 11 |
Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study
|
Gascon, P.
|
|
|
21 |
10 |
p. 2029-2039
|
article
|
| 12 |
Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients
|
Sun, Z.
|
|
|
21 |
10 |
p. 2011-2016
|
article
|
| 13 |
Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy
|
Mitchell, C.L.
|
|
|
21 |
10 |
p. 1982-1989
|
article
|
| 14 |
Impact of adjuvant treatment modalities on the management of patients with stages I–II endometrial stromal sarcoma
|
Malouf, G.G.
|
|
|
21 |
10 |
p. 2102-2106
|
article
|
| 15 |
Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study
|
Sichetti, D.
|
|
|
21 |
10 |
p. 2088-2093
|
article
|
| 16 |
In this issue
|
|
|
|
21 |
10 |
p. 1929
|
article
|
| 17 |
Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients
|
Chua, T.C.
|
|
|
21 |
10 |
p. 2017-2022
|
article
|
| 18 |
Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience
|
Jackson, C.
|
|
|
21 |
10 |
p. 2061-2068
|
article
|
| 19 |
Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients
|
Voskuil, D.W.
|
|
|
21 |
10 |
p. 2094-2101
|
article
|
| 20 |
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
|
Behringer, K.
|
|
|
21 |
10 |
p. 2052-2060
|
article
|
| 21 |
Participation of elderly patients in registration trials for oncology drug applications in Japan †
|
Yonemori, K.
|
|
|
21 |
10 |
p. 2112-2118
|
article
|
| 22 |
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters
|
Fischer, C.A.
|
|
|
21 |
10 |
p. 1961-1966
|
article
|
| 23 |
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary † ‡
|
Chuang, E.
|
|
|
21 |
10 |
p. 2075-2080
|
article
|
| 24 |
Pitfalls in comparing breast cancer survival of elderly patients between hospitals without comorbidity or cause of death data
|
Wear, H.
|
|
|
21 |
10 |
p. 2120
|
article
|
| 25 |
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
|
Cancello, G.
|
|
|
21 |
10 |
p. 1974-1981
|
article
|
| 26 |
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
|
Mesía, R.
|
|
|
21 |
10 |
p. 1967-1973
|
article
|
| 27 |
Recall pneumonitis during systemic treatment with sunitinib
|
Seidel, C.
|
|
|
21 |
10 |
p. 2119-2120
|
article
|
| 28 |
Relapse of renal cell carcinoma with disappearance of HLA class I following hTERT peptide vaccination
|
Yasukawa, M.
|
|
|
21 |
10 |
p. 2122-2124
|
article
|
| 29 |
Reply to Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
|
Rosati, G.
|
|
|
21 |
10 |
p. 2121-2122
|
article
|
| 30 |
Research on cancer prevention, detection and management in low- and medium-income countries
|
Sankaranarayanan, R.
|
|
|
21 |
10 |
p. 1935-1943
|
article
|
| 31 |
Return to work after treatment for breast cancer: single-center experience in a cohort of 273 patients
|
Peugniez, C.
|
|
|
21 |
10 |
p. 2124-2125
|
article
|
| 32 |
Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee
|
Psyrri, A.
|
|
|
21 |
10 |
p. 1952-1960
|
article
|
| 33 |
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor
|
Pandurengan, R.K.
|
|
|
21 |
10 |
p. 2107-2111
|
article
|
| 34 |
Table of Contents
|
|
|
|
21 |
10 |
p. iv-v
|
article
|
| 35 |
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
|
Wheatley-Price, P.
|
|
|
21 |
10 |
p. 2023-2028
|
article
|
| 36 |
The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies
|
Langendijk, J.A.
|
|
|
21 |
10 |
p. 1931-1934
|
article
|
| 37 |
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers
|
Russo, P.
|
|
|
21 |
10 |
p. 2081-2087
|
article
|
Journal description